Connect with us

Key Events This Week: Retail Sales, Fed Speakers And Senate Takes On Stimulus

Key Events This Week: Retail Sales, Fed Speakers And Senate Takes On Stimulus

It’s been a slow start to the week with much of Asia still closed for the Lunar New Year, and the US Presidents’ Day holiday today, although as DB’s Jim Reid…

Published

on

Key Events This Week: Retail Sales, Fed Speakers And Senate Takes On Stimulus

It's been a slow start to the week with much of Asia still closed for the Lunar New Year, and the US Presidents’ Day holiday today, although as DB's Jim Reid writes "it has been a pretty eventful year so far with riots on Capitol Hill, the Georgia election results and huge associated potential stimulus numbers, the taper debate (becalmed for now), various bubble debates, Bitcoin up nearly five-fold since October, the EC vaccine saga, virus mutations, and who can forget the remarkable Reddit story."

Still, as Reid adds, "over the last week or two markets have calmed down and returned to the liquidity/ risk on trade" with the DB strategist predicting that it "will be a very strong year for the global economy as I think life will look very different in the summer (even with some restrictions still), with an abundance of pent up demand. However that will likely bring its own issues with bond yields vulnerable if we see summer inflation (even if only transitory) and if the US technology bubble bursts as the “old” economy becomes relatively more attractive again and as day traders/retail have less time to invest in these chosen stocks. Before we get there the upcoming stimulus checks may find their way into equity markets so if there is a bubble it may inflate more first before any correction. So I reiterate that I don’t think this will be a low vol year so enjoy the quiet period ahead while you can."

But first we have to get through this week, where the main event on the data front, is not until Friday with the next batch of flash PMIs published then. As a reminder, January did see a divergence between the major economies as while a number of composite PMIs were below 50, including the Euro Area, the UK and Japan, the US economy continued to show promising signs, with the composite PMIs rising to the highest level (58.7) since March 2015.

The coming week will also see an increasing amount of hard data releases for January, including retail sales, industrial production, PPI (all Wednesday), housing starts and building permits (both Thursday).

From central banks, the next big round of monetary policy decisions won’t come until mid-March now, but we will get a number of meeting minutes released over the coming week, including from the Federal Reserve (Wednesday), the ECB (Thursday) and the Reserve Bank of Australia. We also get a bunch of Fed speakers. Otherwise, the policy decisions will come from emerging market economies, with Bank Indonesia expected by DB’s economists to cut their policy rate by 25bps on Thursday, and the Central Bank of Turkey also deciding policy that same day.

A full breakdown of economic key events this week is below, courtesy of BofA:

Elsewhere, earnings season is starting to wind down now, with around three-quarters of the S&P 500 having reported. However, the coming week will still see a further 54 in the index report, as well as 67 from the STOXX 600. In terms of the highlights, on Wednesday we’ll hear from Rio Tinto and British American Tobacco, followed by reports on Thursday from Walmart, Nestle, Applied Materials, Airbus, Daimler, Barclays and Credit Suisse. Finally on Friday, releases include Hermes International, Deere & Company, Allianz and NatWest Group.

Source: Earnings whsipers

With the spectacle of the second Trump impeachment officially over, the Senate will now begin to debate the House's stimulus proposals this week. DB's economists believe that it is possible that the Senate could move quickly towards a floor vote without making many changes to the House package. However their base case is that it will take a few weeks as moderate Democrats pare back Biden’s $1.9tn package through amendments. Indeed the House Ways and Means Committee last week took some steps to pare back the number of people eligible for stimulus checks, which lowered the cost of that part of the bill by $60bn.

In terms of latest on the virus, the UK PM Johnson confirmed that his government has met its target of immunising everyone who wanted a jab over the age of 70, along with people who live or work in nursing homes, health service workers and those who are most vulnerable to Covid-19. Meanwhile, Japan is set to begin vaccinations on Wednesday with medical personnel being the first ones to receive the shots.

Courtesy of DB, here is a Day-by-day calendar of events

Monday February 15

  • Data: Euro Area December industrial production
  • Earnings: BHP
  • Other: Presidents’ Day holiday in the US

Tuesday February 16

  • Data: Japan December tertiary industry index, core machine orders (23:50 UK time)
  • Germany February ZEW survey, US February Empire State manufacturing survey, December foreign net transactions
  • Earnings: CVS Health, AIG

Wednesday February 17

  • Data: UK January CPI, EU January new car registrations, Canada January CPI, US January PPI, retail sales, industrial production, capacity utilisation, December business inventories, February NAHB housing market index
  • Central Banks: Federal Reserve release January meeting minutes, Fed’s Rosengren speaks
  • Earnings: Rio Tinto, British American Tobacco

Thursday February 18

  • Data: US January housing starts, building permits, weekly initial jobless claims, February Philadelphia Fed business outlook, Euro Area advance February consumer confidence, Australia flash February manufacturing, services and composite PMIs (22:00 UK time), Japan January nationwide CPI (23:30 UK time)
  • Central Banks: Monetary policy decisions from Bank Indonesia and the Central Bank of Turkey, ECB release January meeting minutes, Fed’s Brainard and Bostic speak
  • Earnings: Walmart, Nestle, Applied Materials, Airbus, Daimler, Barclays, Credit Suisse

Friday February 19

  • Data: Flash February manufacturing, services and composite PMIs from Japan, France, Germany, Euro Area, UK and US, Germany January PPI, UK January retail sales, public sector net borrowing, Canada December retail sales, US January existing home sales
  • Central Banks: Fed’s Rosengren speaks
  • Earnings: Hermes International, Deere & Company, Allianz, NatWest Group

* * *

Finally, looking at just the US, Goldman notes that the key economic data releases this week are the retail sales report on Wednesday and the Philadelphia Fed manufacturing index on Thursday. There are numerous speaking engagements from Fed officials this week.

Monday, February 15

  • There are no major economic data releases scheduled. NYSE will be closed. SIFMA recommends bond markets also close.

Tuesday, February 16

  • 08:30 AM Empire State manufacturing survey, February (consensus +6.3, last +3.5)
  • 11:10 AM Fed Governor Bowman (FOMC voter) speaks: Fed Governor Michelle Bowman will deliver remarks on community bank regulation to the American Bankers Association Conference for Community Bankers. Prepared text and moderated Q&A are expected.
  • 12:30 PM Kansas City Fed President George (FOMC non-voter) speaks: Kansas City Fed President Esther George will speak at the UMKC Real Estate Virtual Symposium. Audience Q&A is expected.
  • 01:00 PM Dallas Fed President Kaplan (FOMC non-voter) speaks: Dallas Fed President Robert Kaplan will discuss the economy at a virtual event hosted by Rice University. Audience Q&A is expected.
  • 03:00 PM San Francisco Fed President Daly (FOMC voter) speaks: San Francisco Fed President Mary Daly will discuss the economy, monetary policy, and inequality at an event hosted by the University of San Francisco.

Wednesday, February 17

  • 08:30 AM PPI final demand, January (GS +0.4%, consensus +0.4%, last +0.3%); PPI ex-food and energy, January (GS +0.2%, consensus +0.2%, last +0.1%); PPI ex-food, energy, and trade, January (GS +0.2%, consensus +0.2%, last +0.4%): We estimate that headline PPI increased by 0.4% in January, reflecting solid increases in energy, food, and core prices. We expect a 0.2% increase in the core measure excluding food and energy, and also a 0.2% increase in the core measure excluding food, energy, and trade, partly reflecting a likely boost from increased Medicare payments.
  • 08:30 AM Retail sales, January (GS +2.0%, consensus +1.0%, last -0.7%); Retail sales ex-auto, January (GS +2.2%, consensus +0.9%, last -1.4%); Retail sales ex-auto & gas, January (GS +2.1%, consensus +0.6%, last -2.1%); Core retail sales, January (GS +2.2%, consensus +0.9%, last -1.9%): We estimate that core retail sales (ex-autos, gasoline, and building materials) rebounded by 2.2% in January (mom sa). High-frequency data suggest a sharp improvement in retail goods spending following the disbursement of the $600 stimulus checks and the reinstatement of unemployment top-up payments. We also expect a partial rebound in restaurant spending that supports the ex-auto ex-gas category. We estimate +2.0% and 2.2% for the headline and ex-auto measures, respectively, reflecting higher auto sales and gasoline prices.
  • 09:00 AM Richmond Fed President Barkin (FOMC voter) speaks: Richmond Fed President Thomas Barkin will take part in a virtual panel discussion hosted by the Maryland Chamber of Commerce.
  • 09:15 AM Industrial production, January (GS +0.5%, consensus +0.4%, last +1.6%): Manufacturing production, January (GS +0.8%, consensus +0.7%, last +0.9%); Capacity utilization, January (GS 75.0%, consensus 74.9%, last 74.5%): We estimate industrial production rose by 0.5% in January, reflecting a further increase in manufacturing production but a pullback in the utilities category. We estimate capacity utilization rose by 0.5pp to 75.0%.
  • 09:15 AM Boston Fed President Rosengren (FOMC non-voter) speaks: Boston Fed President Eric Rosengren will take part in a virtual panel discussion hosted by the Concord Coalition.
  • 10:00 AM NAHB housing market index, February (consensus 83, last 83)
  • 02:00 PM Minutes from the January 26-27 FOMC meeting: At its January meeting, the FOMC left the funds rate target range unchanged at 0–0.25%, as widely expected. During the press conference, Chair Powell said the focus on tapering is “premature.”

Thursday, February 18

  • 08:00 AM Fed Governor Brainard (FOMC voter) speaks: Fed Governor Lael Brainard will speak at a climate finance summit hosted by the Institute for International Finance. Text and moderated Q&A are expected.
  • 08:30 AM Housing starts, January (GS flat, consensus -0.7%, last +5.8%); Building permits, January (consensus -2.0%, last +4.5%): We estimate housing starts remained unchanged in January. Our forecast incorporates higher permits but a small drag from snowfall early in the month.
  • 08:30 AM Initial jobless claims, week ended February 13 (GS 725k, consensus 765k, last 793k); Continuing jobless claims, week ended February 6, consensus 4,423k, last 4,545k): We estimate initial jobless claims declined to 725k in the week ended February 13.
  • 08:30 AM Import price index, January (consensus +1.0%, last +0.9%)
  • 08:30 AM Philadelphia Fed manufacturing index, February (GS 18.0, consensus 20.0, last 26.5): We estimate that the Philadelphia Fed manufacturing index declined in February to 18.0, reflecting reversion after a large jump in January and weaker business confidence measures in the beginning of February.
  • 10:00 AM Atlanta Fed President Bostic (FOMC voter) speaks: Atlanta Fed President Raphael Bostic will take part in a virtual discussion on educational inequality.

Friday, February 19

  • 08:00 AM Richmond Fed President Barkin (FOMC voter) speaks; Richmond Fed President Thomas Barkin will take part in a virtual discussion hosted by the Rockingham Chamber of Commerce.
  • 09:45 AM Markit Flash US manufacturing PMI, February preliminary (consensus 58.5, last 59.2)
  • 09:45 AM Markit Flash US services PMI, February preliminary (consensus 57.9, last 58.3)
  • 10:00 AM Existing home sales, January (GS -3.0%, consensus -2.0%, last +0.7%): We estimate that existing home sales declined by 3.0% in January after edging up 0.7% in December. Existing home sales are an input into the brokers' commissions component of residential investment in the GDP report.
  • 11:00 AM Boston Fed President Rosengren (FOMC non-voter) speaks: Boston Fed President Eric Rosengren will give a virtual speech to the Yale Economics Development Symposium. Prepared text and audience Q&A are expected.

Source: DB, BofA, Goldman

Tyler Durden Mon, 02/15/2021 - 13:25

Read More

Continue Reading

International

Analyst reviews Apple stock price target amid challenges

Here’s what could happen to Apple shares next.

Published

on

They said it was bound to happen.

It was Jan. 11, 2024 when software giant Microsoft  (MSFT)  briefly passed Apple  (AAPL)  as the most valuable company in the world.

Microsoft's stock closed 0.5% higher, giving it a market valuation of $2.859 trillion. 

It rose as much as 2% during the session and the company was briefly worth $2.903 trillion. Apple closed 0.3% lower, giving the company a market capitalization of $2.886 trillion. 

"It was inevitable that Microsoft would overtake Apple since Microsoft is growing faster and has more to benefit from the generative AI revolution," D.A. Davidson analyst Gil Luria said at the time, according to Reuters.

The two tech titans have jostled for top spot over the years and Microsoft was ahead at last check, with a market cap of $3.085 trillion, compared with Apple's value of $2.684 trillion.

Analysts noted that Apple had been dealing with weakening demand, including for the iPhone, the company’s main source of revenue. 

Demand in China, a major market, has slumped as the country's economy makes a slow recovery from the pandemic and competition from Huawei.

Sales in China of Apple's iPhone fell by 24% in the first six weeks of 2024 compared with a year earlier, according to research firm Counterpoint, as the company contended with stiff competition from a resurgent Huawei "while getting squeezed in the middle on aggressive pricing from the likes of OPPO, vivo and Xiaomi," said senior Analyst Mengmeng Zhang.

“Although the iPhone 15 is a great device, it has no significant upgrades from the previous version, so consumers feel fine holding on to the older-generation iPhones for now," he said.

A man scrolling through Netflix on an Apple iPad Pro. Photo by Phil Barker/Future Publishing via Getty Images.

Future Publishing/Getty Images

Big plans for China

Counterpoint said that the first six weeks of 2023 saw abnormally high numbers with significant unit sales being deferred from December 2022 due to production issues.

Apple is planning to open its eighth store in Shanghai – and its 47th across China – on March 21.

Related: Tech News Now: OpenAI says Musk contract 'never existed', Xiaomi's EV, and more

The company also plans to expand its research centre in Shanghai to support all of its product lines and open a new lab in southern tech hub Shenzhen later this year, according to the South China Morning Post.

Meanwhile, over in Europe, Apple announced changes to comply with the European Union's Digital Markets Act (DMA), which went into effect last week, Reuters reported on March 12.

Beginning this spring, software developers operating in Europe will be able to distribute apps to EU customers directly from their own websites instead of through the App Store.

"To reflect the DMA’s changes, users in the EU can install apps from alternative app marketplaces in iOS 17.4 and later," Apple said on its website, referring to the software platform that runs iPhones and iPads. 

"Users will be able to download an alternative marketplace app from the marketplace developer’s website," the company said.

Apple has also said it will appeal a $2 billion EU antitrust fine for thwarting competition from Spotify  (SPOT)  and other music streaming rivals via restrictions on the App Store.

The company's shares have suffered amid all this upheaval, but some analysts still see good things in Apple's future.

Bank of America Securities confirmed its positive stance on Apple, maintaining a buy rating with a steady price target of $225, according to Investing.com

The firm's analysis highlighted Apple's pricing strategy evolution since the introduction of the first iPhone in 2007, with initial prices set at $499 for the 4GB model and $599 for the 8GB model.

BofA said that Apple has consistently launched new iPhone models, including the Pro/Pro Max versions, to target the premium market. 

Analyst says Apple selloff 'overdone'

Concurrently, prices for previous models are typically reduced by about $100 with each new release. 

This strategy, coupled with installment plans from Apple and carriers, has contributed to the iPhone's installed base reaching a record 1.2 billion in 2023, the firm said.

More Tech Stocks:

Apple has effectively shifted its sales mix toward higher-value units despite experiencing slower unit sales, BofA said.

This trend is expected to persist and could help mitigate potential unit sales weaknesses, particularly in China. 

BofA also noted Apple's dominance in the high-end market, maintaining a market share of over 90% in the $1,000 and above price band for the past three years.

The firm also cited the anticipation of a multi-year iPhone cycle propelled by next-generation AI technology, robust services growth, and the potential for margin expansion.

On Monday, Evercore ISI analysts said they believed that the sell-off in the iPhone maker’s shares may be “overdone.”

The firm said that investors' growing preference for AI-focused stocks like Nvidia  (NVDA)  has led to a reallocation of funds away from Apple. 

In addition, Evercore said concerns over weakening demand in China, where Apple may be losing market share in the smartphone segment, have affected investor sentiment.

And then ongoing regulatory issues continue to have an impact on investor confidence in the world's second-biggest company.

“We think the sell-off is rather overdone, while we suspect there is strong valuation support at current levels to down 10%, there are three distinct drivers that could unlock upside on the stock from here – a) Cap allocation, b) AI inferencing, and c) Risk-off/defensive shift," the firm said in a research note.

Related: Veteran fund manager picks favorite stocks for 2024

Read More

Continue Reading

International

Major typhoid fever surveillance study in sub-Saharan Africa indicates need for the introduction of typhoid conjugate vaccines in endemic countries

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high…

Published

on

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

Credit: IVI

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

 

The findings from this 4-year study, the Severe Typhoid in Africa (SETA) program, offers new typhoid fever burden estimates from six countries: Burkina Faso, Democratic Republic of the Congo (DRC), Ethiopia, Ghana, Madagascar, and Nigeria, with four countries recording more than 100 cases for every 100,000 person-years of observation, which is considered a high burden. The highest incidence of typhoid was found in DRC with 315 cases per 100,000 people while children between 2-14 years of age were shown to be at highest risk across all 25 study sites.

 

There are an estimated 12.5 to 16.3 million cases of typhoid every year with 140,000 deaths. However, with generic symptoms such as fever, fatigue, and abdominal pain, and the need for blood culture sampling to make a definitive diagnosis, it is difficult for governments to capture the true burden of typhoid in their countries.

 

“Our goal through SETA was to address these gaps in typhoid disease burden data,” said lead author Dr. Florian Marks, Deputy Director General of the International Vaccine Institute (IVI). “Our estimates indicate that introduction of TCV in endemic settings would go to lengths in protecting communities, especially school-aged children, against this potentially deadly—but preventable—disease.”

 

In addition to disease incidence, this study also showed that the emergence of antimicrobial resistance (AMR) in Salmonella Typhi, the bacteria that causes typhoid fever, has led to more reliance beyond the traditional first line of antibiotic treatment. If left untreated, severe cases of the disease can lead to intestinal perforation and even death. This suggests that prevention through vaccination may play a critical role in not only protecting against typhoid fever but reducing the spread of drug-resistant strains of the bacteria.

 

There are two TCVs prequalified by the World Health Organization (WHO) and available through Gavi, the Vaccine Alliance. In February 2024, IVI and SK bioscience announced that a third TCV, SKYTyphoid™, also achieved WHO PQ, paving the way for public procurement and increasing the global supply.

 

Alongside the SETA disease burden study, IVI has been working with colleagues in three African countries to show the real-world impact of TCV vaccination. These studies include a cluster-randomized trial in Agogo, Ghana and two effectiveness studies following mass vaccination in Kisantu, DRC and Imerintsiatosika, Madagascar.

 

Dr. Birkneh Tilahun Tadesse, Associate Director General at IVI and Head of the Real-World Evidence Department, explains, “Through these vaccine effectiveness studies, we aim to show the full public health value of TCV in settings that are directly impacted by a high burden of typhoid fever.” He adds, “Our final objective of course is to eliminate typhoid or to at least reduce the burden to low incidence levels, and that’s what we are attempting in Fiji with an island-wide vaccination campaign.”

 

As more countries in typhoid endemic countries, namely in sub-Saharan Africa and South Asia, consider TCV in national immunization programs, these data will help inform evidence-based policy decisions around typhoid prevention and control.

 

###

 

About the International Vaccine Institute (IVI)
The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.

IVI’s current portfolio includes vaccines at all stages of pre-clinical and clinical development for infectious diseases that disproportionately affect low- and middle-income countries, such as cholera, typhoid, chikungunya, shigella, salmonella, schistosomiasis, hepatitis E, HPV, COVID-19, and more. IVI developed the world’s first low-cost oral cholera vaccine, pre-qualified by the World Health Organization (WHO) and developed a new-generation typhoid conjugate vaccine that is recently pre-qualified by WHO.

IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, a Country Office in Austria, and Collaborating Centers in Ghana, Ethiopia, and Madagascar. 39 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, and Thailand provide state funding. For more information, please visit https://www.ivi.int.

 

CONTACT

Aerie Em, Global Communications & Advocacy Manager
+82 2 881 1386 | aerie.em@ivi.int


Read More

Continue Reading

International

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

Earlier today, CNBC’s…

Published

on

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever... And Debt Explodes

Earlier today, CNBC's Brian Sullivan took a horse dose of Red Pills when, about six months after our readers, he learned that the US is issuing $1 trillion in debt every 100 days, which prompted him to rage tweet, (or rageX, not sure what the proper term is here) the following:

We’ve added 60% to national debt since 2018. Germany - a country with major economic woes - added ‘just’ 32%.   

Maybe it will never matter.   Maybe MMT is real.   Maybe we just cancel or inflate it out. Maybe career real estate borrowers or career politicians aren’t the answer.

I have no idea.  Only time will tell.   But it’s going to be fascinating to watch it play out.

He is right: it will be fascinating, and the latest budget deficit data simply confirmed that the day of reckoning will come very soon, certainly sooner than the two years that One River's Eric Peters predicted this weekend for the coming "US debt sustainability crisis."

According to the US Treasury, in February, the US collected $271 billion in various tax receipts, and spent $567 billion, more than double what it collected.

The two charts below show the divergence in US tax receipts which have flatlined (on a trailing 6M basis) since the covid pandemic in 2020 (with occasional stimmy-driven surges)...

... and spending which is about 50% higher compared to where it was in 2020.

The end result is that in February, the budget deficit rose to $296.3 billion, up 12.9% from a year prior, and the second highest February deficit on record.

And the punchline: on a cumulative basis, the budget deficit in fiscal 2024 which began on October 1, 2023 is now $828 billion, the second largest cumulative deficit through February on record, surpassed only by the peak covid year of 2021.

But wait there's more: because in a world where the US is spending more than twice what it is collecting, the endgame is clear: debt collapse, and while it won't be tomorrow, or the week after, it is coming... and it's also why the US is now selling $1 trillion in debt every 100 days just to keep operating (and absorbing all those millions of illegal immigrants who will keep voting democrat to preserve the socialist system of the US, so beloved by the Soros clan).

And it gets even worse, because we are now in the ponzi finance stage of the Minsky cycle, with total interest on the debt annualizing well above $1 trillion, and rising every day

... having already surpassed total US defense spending and soon to surpass total health spending and, finally all social security spending, the largest spending category of all, which means that US debt will now rise exponentially higher until the inevitable moment when the US dollar loses its reserve status and it all comes crashing down.

We conclude with another observation by CNBC's Brian Sullivan, who quotes an email by a DC strategist...

.. which lays out the proposed Biden budget as follows:

The budget deficit will growth another $16 TRILLION over next 10 years. Thats *with* the proposed massive tax hikes.

Without them the deficit will grow $19 trillion.

That's why you will hear the "deficit is being reduced by $3 trillion" over the decade.

No family budget or business could exist with this kind of math.

Of course, in the long run, neither can the US... and since neither party will ever cut the spending which everyone by now is so addicted to, the best anyone can do is start planning for the endgame.

Tyler Durden Tue, 03/12/2024 - 18:40

Read More

Continue Reading

Trending